Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety
Journal
Journal of the Formosan Medical Association
Date Issued
2022
Author(s)
Feng Y.-H.
Yen C.-J.
Yang T.-S.
Chao Y.
Chen J.-S.
Su C.-Y.
Chen W.-J.
Hsiang H.-L.
SDGs
Publisher
Elsevier B.V.
Type
journal article